Purpose: This study analyzed the protective effects of enoxaparin in rat uteruses by exposing the uterus to experimental ischemia-reperfusion injury. Methods: Thirty female rats were homogenized by ...
Abstract: This study aims to optimize the dynamic administration regimen of prophylactic enoxaparin in critically ill patients to reduce the risk of VTE, major bleeding, and 30-day all-cause mortality ...
Purpose. A case of fatal retroperitoneal hematoma that developed after enoxaparin administration in a woman with paroxysmal atrial flutter and chest pain is reported. Summary. A 63-year-old, 74-kg, ...
Am J Health Syst Pharm. 2010;67(10):806-809. The patient had no signs or symptoms of retroperitoneal hematoma until she became acutely hypotensive approximately 48 hours after the administration of ...
The influence of low molecular weight heparine (Clexane) on healing of abdominal wounds in rats was studied. Subcutaneous injections of standard dose of clexane or physiologic saline were given to ...
A more selective risk-stratified approach to postpartum enoxaparin (Lovenox) thromboprophylaxis for venous thromboembolism (VTE) was linked to reduced rates of wound hematomas without increasing the ...
Background: Anti-factor Xa activity has been suggested as a surrogate parameter for judging the effectiveness of pharmacological thromboprophylaxis with low molecular weight heparins in critically ill ...
Apotex recalled two batches of mislabeled enoxaparin sodium syringes Enoxaparin is used to prevent blood clots It should not be stopped without doctors' advice A pharmaceutical company is recalling ...
Background: Heparin administration in COVID-19 patients is recommended by expert consensus, although evidence about dosage, duration and efficacy are limited. We aim to investigate the association ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results